2016-02-10 20:31:52 UTC

Pfizer Now Accepting Applications for IBD Research Grant Awards

Feb. 10, 2016

The deadline to submit applications is March 14, 2016.

We wanted to make you aware of a new grant opportunity. Pfizer is now accepting applications for its 2016 Research Awards Program that supports the research of autoimmune diseases, including IBD. The ASPIRE, or Advancing Science through Pfizer Investigator Research Exchange, program, is a competitive, peer-reviewed grants program.

The grants are designed to support researchers in “basic science, and translational and clinical research that advances medical knowledge in the pathogenesis, treatment and prevention of selected diseases,” according to the company's announcement. Pfizer also noted that it is funding research up to a maximum of $150,000 per award, but that larger grants may also be considered in some circumstances.

The deadline to submit applications is March 14, 2016, and the program is only open to U.S. investigators.

Learn more about the ASPIRE awards program.

More on Crohn's Disease

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Jan. 18, 2018

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

Putting Patients First: Digital Health Tools to Empower IBD Patients

Jan. 18, 2018

Discover how advances in digital health can help you monitor and support IBD patients remotely and dynamically, improve face-to-face care, and drive clinical decisions through shared decision-making.

Get Your Questions Answered on Biosimilar Therapies

Dec. 7, 2017

Join inflammatory bowel disease (IBD) experts on Dec. 11, 2017, 8-8:45 p.m. ET, for a free webinar on biosimilar therapies.